Dr. Peter Black is a Senior Research Scientist at the Vancouver Prostate Centre and Professor in the Department of Urologic Sciences at the University of British Columbia. He has a translational research interest in bladder cancer with a focus on resistance to chemotherapy and immunotherapy and the development of novel targeted therapies to overcome resistance.

Dr. Black is Surgical Oncology Co-Chair of the NCI Bladder Cancer Task Force and Chair of the AUA Research Grants & Investigator Support Committee. He is Chair of the Canadian Bladder Cancer Network and General Secretary of the International Bladder Cancer Network. He is the Editor-in-Chief of the Société Internationale d’Urologie Journal.

Kim Chi is a medical oncologist and the Chief Medical Officer of BC Cancer, which provides a comprehensive cancer control program for the people of British Columbia (BC), in Canada. He is also Professor in the Faculty of Medicine at the University of British Columbia, a Professor in the Faculty of Health Sciences at Simon Fraser University, and the Shrum Chair in Prostate Cancer Research at BC Cancer.
Prof. Chi's research in the field of genitourinary cancers focuses on prostate cancer and investigational new drugs, where he has contributed to changing international standards of care practice for patients with advanced prostate cancer. Recently, he has been investigating circulating tumour DNA as a potential prognostic and predictive biomarker for patients with castration-resistant prostate cancer. Prof. Chi is the past-Chair of the Genitourinary Disease Site Committee for the Canadian Cancer Trials Group, and has held peer-reviewed grant funding from the Canada Institutes of Health Research (CIHR), National Cancer Institute of Canada (NCIC)/Canadian Cancer Society (CCS), the US Department of Defence, Movember, Prostate Cancer Foundation (USA), and Prostate Cancer Canada.
Prof. Chi has published over 250 articles in prestigious peer-reviewed journals including most recently the Journal of Clinical Oncology, Annals of Oncology, Nature, the New England Journal of Medicine, and Lancet Oncology.

Clinical Associate Professor, Univeristy of British Columbia
Medical Oncologist, BC Cancer Agency
Provincial Director, Systemic Therapy Clinical Trials
Dr. Eigl is a medical oncologist specializing in genitourinary oncology, with a special research interest in bladder and prostate cancers. He presently leads several clinical trials evaluating novel therapies such as antisense oligonucleotides and oncolytic viruses in these disease settings. He is active in national and international clinical trials and is a member of the National Cancer Institute of Canada GU Clinical Trials Group and Canadian Uro-Oncology Group.

Dr. Eigl rejoined the Prostate Centre in 2012. After completing a research fellowship here in 2004, he took a leadership position in genitourinary research in Calgary, Alberta. During his tenure there he was the Head of the Genitourinary Tumor Research Group, Medical Director of theClinical Trials Unit, and the Director of the Alberta Clinical Cancer Research Unit (ACCRU).

In returning to British Columbia, Dr. Eigl has taken on a provincial leadership role for systemic therapy clinical trials, which provides access to clinical trials for all cancer patients in British Columbia through the six regional cancer centres.

Dr. Gleave is a Distinguished Professor and Chairman of the Department of Urologic Sciences at UBC, and a British Columbia Leadership Chair. He is Co-Founder and Director of the Vancouver Prostate Centre, now a UBC and National Centre of Excellence. He is amongst the top cited and funded scientists in Canada, publishing > 600 papers with >60,000 citations, an H-Index of 122, and attracting >$120M in research funding. Dr. Gleave is a surgeon-scientist whose research characterizes molecular mechanisms mediating treatment resistance in cancer, and designing co-targeting strategies to improve cancer control. He patented several anti-cancer drugs and founded OncoGenex Pharmaceuticals to develop OGX-011 and OGX-427, inhibitors of cytoprotective chaperones clusterin and Hsp27 which progressed to Phase III and Phase II trials world-wide. OncoGenex was awarded Canadian Biotech Company of the Year in 2010. Dr. Gleave also recently co-founded Sitka and Sustained Therapeutics.

In 2017, Dr. Gleave was appointed to the Order of Canada for his leadership role in developing new treatments for prostate cancer and for his research on mechanisms mediating treatment resistance in cancer. In 2020, he was inducted as a Fellow in the National Academy of Inventors.

Dr Gleave is the recipient of numerous awards, including the 2018 Dr. Chew Wei Memorial Prize in Cancer Research, the Huggins Medal from the SUO in 2018, the Richard Williams Award from the AUA in 2017, the Barringer Medal from the American Association of GU Surgeons; the Eugene Fuller Award from the American Urological Association in 2013; the Aubrey Tingle Prize from the Michael Smith Foundation for Health Research; and the NCIC William Rawls Award for contributions to cancer control in Canada; He was appointed a Distinguished University Scholar at UBC in 2003 and awarded a BC Leadership Chair in 2005, the 2006 BC Biotech Award for Innovation and Achievement, and the 2007 BC Innovation Council Frontiers in Research Award.

M.D. Technical University of Munich, Germany 1995
Internal Medicine, University of Tuebingen 2001
Hematology/Oncology, University of Tuebingen, 2003
Fellow, Royal College of Physicians & Surgeons of Canada 2008

Christian Kollmannsberger, MD, FRCPC, is staff medical oncologist at the British Columbia Cancer Agency (BCCA) Vancouver Cancer Centre and Clinical Professor at the University of British Columbia. He graduated from the Technical University in Munich, Germany and received his clinical training in Internal Medicine, Hematology and Medical Oncology, mainly at University of Tuebingen, Germany.

Dr. Kollmannsberger's research is concentrated on genitourinary malignancies with a special interest in testicular and renal cell cancer. His research is focused on the investigation of mechanisms of treatment resistance, the development of novel treatment options and biomarkers, including miRNA-371/375 and others for testicular cancer.

Nationally and internationally, he has contributed to numerous trials in the field of renal cell carcinoma and testicular cancer. He has repeatedly served as faculty and member of the education/scientific committee for the Annual meeting of the American Society of Clinical Oncology (ASCO), the ASCO Genitourinary Cancers Symposium, and the Annual Meeting of the European Society of Medical Oncology (ESMO).

Currently, Dr. Kollmannsberger serves as chair of the BC Cancer Provincial Genitourinary Tumor Group, chair for the Genitourinary Systemic Therapy Clinical Trials Unit at BC Cancer Vancouver Centre, chair for the Canadian Clinical Trials Group Testis Cancer Disease Oriented Group, and member of the Canadian Clinical Trials Group Kidney Cancer Disease Oriented Group.

Dr. Nappi is an assistant professor in the department of Urologic Sciences at the University of British Columbia and a senior research scientist at the Vancouver Prostate and works as medical oncologist in the GU group at the BC Cancer in Vancouver.
Her main research focus involves discovery and validation of biomarkers in GU cancers, mainly in prostate and testis cancer patients.
She has got several grants and awards including the Prostate Cancer Foundation Young Investigator award and the Michael Smith Foundation Health Professional Investigator award (2020), the operational CIHR grant in 2021, a R01/R37 NIH grant and the career development award from the US department of defense (2022).
Lucia is the vice-chair of the SWOG Adolescent and Young Adults (AYA) committee and the co-chair of the international SWOG- S1823 cohort study and the chair of the Canadian GCC.1 equivalent study through the Canadian Cancers Trial Group (CCTGG).

Dr. Krista Noonan is a medical oncologist specializing in genitourinary and thoracic malignancies at BC Cancer, Surrey Centre and a clinical assistant professor at the University of British Columbia. She is the BC GU Systemic Chair. She received a BSc in Biochemistry and an MD from Memorial University, Newfoundland in 2008 followed by a residency in Internal Medicine. Dr. Noonan subsequently completed her Medical Oncology and Thoracic Oncology fellowships at the BC Cancer Vancouver, as well as a diploma in Clinical Epidemiology from Memorial University. She enjoys teaching a mentoring students and residents. Her research interests’ focus are in genitourinary and thoracic malignancies and health services research.

Dr. Nappi is an assistant professor in the department of Urologic Sciences at the University of British Columbia and a senior research scientist at the Vancouver Prostate and works as medical oncologist in the GU group at the BC Cancer in Vancouver.
Her main research focus involves discovery and validation of biomarkers in GU cancers, mainly in prostate and testis cancer patients.
She has got several grants and awards including the Prostate Cancer Foundation Young Investigator award and the Michael Smith Foundation Health Professional Investigator award (2020), the operational CIHR grant in 2021, a R01/R37 NIH grant and the career development award from the US department of defense (2022).
Lucia is the vice-chair of the SWOG Adolescent and Young Adults (AYA) committee and the co-chair of the international SWOG- S1823 cohort study and the chair of the Canadian GCC.1 equivalent study through the Canadian Cancers Trial Group (CCTGG).

Burnaby Hospital Regional Cancer Center
Director, BC Community Oncology Trialists
Burnaby, BC
Dr. Simon Yu is a medical oncologist practicing at Burnaby Hospital and Ridge Meadows Hospital in British Columbia. He completed his internal medicine and medical oncology residency at University of British Columbia and BC Cancer Agency. His practice consists of almost all solid tumors and select hematologic malignancies.

My name is Dr. Joanna Vergidis. I am a Medical Oncologist at BC Cancer – Victoria. I treat GU and dermatologic malignancies. I am the Department Head for Medical Oncology since 2020.

Bio to come

Dr Brown is a UBC Radiology graduate and Clinical Assistant Professor UBC. She is currently a staff Radiologist at BC Cancer, Vancouver and the Lower Mainland Medical Imaging CT Medical Practice Lead. A lifelong enjoyment of the outdoors and a love for all living things led to her interest in climate change and biodiversity loss. In the last several years, she has obtained a Climate Change and Health certificate from Yale, a Cascades Canada certificate in Fundamentals of Sustainable Health Systems; and is one of two Canadians in the US Climate Advocacy Lab Health Care Leaders peer learning circle. Dr Brown co-chairs the provincial BC Cancer Planetary Health Unit which she co-founded in spring 2022. She is currently enrolled in the UBC Masters of Health Administration program, School of Population and Public Health (2021-2023), where her capstone project is focussed on engagement of frontline workers in low carbon, sustainable change within the health care system.

Head of Surgery Surrey Memorial Hospital 2017 to present

Active privileges SMH, Jim Pattison Outpatient Surgical Centre and Delta Hospital and Valley Surgical Centre
Strong clinical interest in Urologic Oncology, benign prostate disease, female and male incontinence, as well as stone disease.

EDUCATION
Urology Residency UBC 1992-1995
Cardiac Surgery Assistant, St Paul’s Hospital 1991-1992
General Surgery Residency 1990-1991
General Practitioner, Prince George 1989-1990
Rotating Internship, St. Paul’s Hospital 1987-1988
University of Alberta Medical School , MD 1984-1987

Bachelor of Science Degree U of A (Pscychology) 1980-1984

BC Cancer, Victoria
Victoria, BC

Dr Andrew Attwell is a Medical Oncologist working since 2003 at BC Cancer, Victoria. His tumor sites include genitourinary, gynecological and CNS malignancies. He is a UBC Clinical Assistant Professor, participates in clinical trials and teaching, has a busy family and is an avid cyclist.

Dr. Bains completed her internal medicine training at MUN (Nfld) in 2013.
She then completed her medical oncology training at Dal (NS) in 2015.
Dr. Banis worked as a locum medical oncologist in Halifax and St. John’s for the next 1.5 years.
She then moved to the UK to do genitourinary and clinical trials fellowship at Guy’s Hospital in London until Sept 2018.
Dr. Bains joined BC Cancer Kelowna in September 2019.

Dr Crook did her medical training at the University of Toronto, Residency in Radiation Oncology at the Princess Margaret Hospital and is currently a Full Professor of Radiation Oncology at the University of British Columbia. She is a staff Radiation Oncologist in Kelowna BC where she has developed image-guided HDR gynecologic brachytherapy, US-planned HDR prostate brachytherapy, HDR interstitial and surface mold penile brachytherapy and permanent seed brachytherapy for breast cancer. She is former president of the Board of the American Brachytherapy Society, recipient of the Thom Shanahan Distinguished Brachytherapy Educator Award and the ABS 2017 Henschke Award.
She is also the first to hold a Brachytherapy Research Chair position in British Columbia.

I’m a radiation oncologist who recently took up a position in Prince George.
I currently treat GU, upper and lower GI and skin.

Originally from Uganda, I grew up in South Africa and attended medical school in Durban at the University of KwaZulu-Natal. Following my internship year in Mthatha I moved to South Yorkshire for core medical training in gained membership of the Royal College of Physicians UK.
I then moved to Belfast for clinical oncology training culminating in earning my FRCR (Fellowship of the Royal College of Radiologists).
In 2019, I moved to Calgary for a combined SBRT and head and neck fellowship.
Following that I moved to Halifax for a locum post for 2 years before moving to BC.

I have a keen interest in education and have been involved in teaching of medical students and residents through residency and as a consultant.
Outside of work I enjoy spending time with my family (wife and 2 sons), building lego, travelling (pre-pandemic) and I once was a half decent cricketer.

Head, Division of Urology, Providence Health Care, Vancouver, BC
Clinical Assistant Professor, Department of Urologic Sciences, UBC
MD- University of Calgary 2002
FRCSC (Urology) – University of British Columbia 2007
Minimally Invasive Urology Fellowship, University of Chicago, Chicago, IL 2008
Renal and Pancreas Transplantation Fellowship, St. Vincent Medical Center, Los Angeles, CA 2009

Originally from Calgary, Alberta, Dr. Michael Eng is a graduate of the UBC Urology Residency Program in 2007. He practices Urology and Renal Transplantation at Providence Health Care in Vancouver. He is primarily based at St. Paul’s Hospital but also works at Mount Saint Joseph’s Hospital.

Dr. Eng completed a Minimally Invasive Urology Fellowship at the University of Chicago, focusing on robotic and laparoscopic surgery for the management of prostate, renal and bladder cancers. Dr. Eng subsequently completed a Transplantation Fellowship at St. Vincent Medical Center in Los Angeles, which was one of the largest Kidney and Pancreas Transplantation programs in Southern California.

Medical Oncologist, BC Cancer - Victoria
richard.gagnon@bccancer.bc.ca

I am thrilled to have joined the BCCA – Victoria site in August 2022 after completing my internal medicine and medical oncology residency training at the University of Calgary. I am part of the GU, breast, and gyne tumor groups. My academic interests include real world clinical outcomes and biomarkers, particularly in the GU realm. When I’m not at work, I love being on my bike and spending time exploring Vancouver Island with my wife and baby daughter.

Matthew Ho completed his medical school and Urology residency at the University of British Columbia. He is currently in his final year of an SUO-accredited Urologic Oncology fellowship at the University of Chicago. After fellowship, he is excited to be joining the Urology staff at Kelowna General Hospital.

Dr. Hoag is a urologist in North Vancouver at Lions Gate Hospital. He has a fellowship in advanced minimally invasive urologic surgery and a practice focus in minimally invasive surgical management of urologic cancers. He has been President of the BC Urological Society since 2018 and President of Consultant Specialists of BC since 2021.

Dr. Michael Humphreys is a BC Cancer Medical Oncologist in Vernon, BC who treats GU, Lung, GI, Breast and Melanoma. Med Onc residency at the Cross Cancer Institute. Now in 12th year of practice. His favourite activity is skiing with his wife and their 5 children ages 5-11.

Division of Surgery, University of British Columbia
B.C. Cancer Agency, Vancouver Cancer Centre
600 West 10th Ave, Vancouver, B.C. V5Z 4E6
Tel 604-877-6000 Fax 604-877-0585
E-mail: mkeyes@bccancer.bc.ca

Dr. Keyes is a Clinical Professor in Radiation Oncology, University of British Columbia (UBC), a Fellow (FABS) of American Brachytherapy Society (ABS), ABS board member, recipient of ABS President Award and a Vice-Chair of the Royal College of Physicians and Surgeons of Canada AFC (Area of Focused Competence) Diploma in Brachytherapy. She is an AFC program director at UBC, former UBC Radiation Oncology Residency Training Program director and recipient of several teaching and mentorship awards. She is a CARO and BC Cancer wellness committee chair. Dr. Keyes is a keynote speaker at international conferences an author of over 100 peer-reviewed manuscripts. She holds CIHR and Michael Smith Foundation grant for translational research in prostate cancer.

Daniel Khalaf is staff Medical Oncologist at BC Cancer since 2019, where he currently treats GU and breast Cancers.

He completed his training in Hematology and Oncology at the University of Montreal in 2015, and did a 2 - year fellowship in Prostate Cancer and translational research with Dr Kim Chi.
He collaborated on work with the Wyatt Lab throughout his fellowship, with publications on biomarkers in metastatic prostate cancer on the heels of which he won a 2020 Prostate Cancer Young Investigator Award.

His research interests also include clinical outcomes in vulnerable populations such as the elderly, and quality of life outcomes.

University of Cape Town Faculty of Medicine, South Africa
Radiation Oncology Residency BCC Vancouver
Staff Radiation Oncologist BCC Vancouver 1991
Clinical Professor UBC Faculty of Medicine

Biographic Summary
Medical Leader Hereditary Cancer Program 1998-2005
Director Hereditary Cancer Program 2006-2008
President British Columbia Association of Radiation Oncologists 1999-2001
Chair Medical Advisory Committee 2001-2003
Member Board of Trustees BC Cancer Agency 2001-2002
Skin Tumour Group Chair 2003-2006

Dr May Cohen Award from the Federation of Medical Women for the Promotion of Women’s Health August 2000
Canadian Breast Cancer Foundation Professional Achievement Award 2003

A graduate of UBC Urology 1997, Dr Kinahan started out in Vancouver and moved to Victoria. He spent his travelling fellowship in London and Stanford/UCSF 1998-1999 in
Endourology and Reconstructive urology. Currently focused on oncology and Reconstructive urology, with special interests in continent urinary diversion, oncology Prosthetics and Lasers/PCNL.

Currently acting director of Urology QA and our island Journal review/education, John takes an active role in VIGU meetings and is proud to be a BC GUTG member.

Dr Kinahan lives in Victoria with his three sons and enjoys family time, skiing, cycling and golf.

Dr. Lavoie is a medical oncologist working at BC Cancer – Victoria, where he treats GU, GI and head and neck cancers.

Dr. Lyly Le, MD CM, FRCP(C), is a Medical Oncologist at BC Cancer – Surrey and Clinical Assistant Professor in the UBC Department of Medicine, Division of Medical Oncology. She has been in Surrey since 2004 after completing a two-year IND fellowship at Princess Margaret Hospital with a focus on gastrointestinal and genitourinary cancers which continue to be her tumour sites. Her interests have morphed over time from clinical trials to clinical informatics. Please do not ask her about CST today.

Dr. Justin Lee received his medical degree from the University of British Columbia followed by his Postgraduate Residency Training in Urology at the University of Toronto. Following residency, Dr. Lee completed a two-year fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center in New York in 2016. During his fellowship, he completed a Masters of Public Health in Clinical Effectiveness at the Harvard School of Public Health in Boston. Dr. Lee works alongside the North Shore urology group at Lions Gate Hospital. He has special interest in the diagnosis and management of cancers affecting the genitourinary tract. He has subspecialized training in minimally invasive laparoscopic surgery and open surgical treatment of urologic cancers. He is active in clinical research and medical education. He serves on the Quality of Life Committee for the Canadian Cancer Trials Group and his research interest is in Patient Reported Outcomes.

Associate Professor, Department of Radiology, Faculty of Medicine, University of British Columbia
Associate Professor, School of Biomedical Engineering, Faculty of Applied Sciences, University of British Columbia
Voluntary Professor, Department of Interventional Radiology, Miller School of Medicine, University of Miami
Vancouver, BC

Dr. David M Liu MD is a board certified in both Canada and the US, practicing at the Vancouver General Hospital, University of British Columbia Hospital and the BC Cancer Agency with a cross appointment in the Department of Surgery. Dr. Liu received his medical degree from University of Toronto, completed his radiology residency at University of British Columbia, Interventional Radiology fellowship at Northwestern Memorial Hospital, and has practiced in both the US and Canada.

In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer related thromboembolic disease, Dr. Liu maintains an interventional oncology practice incorporating all aspects of embolization, ablation, venous access, and palliative therapy in all organ systems. He is the co-founder and co-chair of the international liver cancer symposium, SHOW, and has been credited with 7 book chapters, over 70 publications, and over 100 invited lectures around the world. Dr. Liu an active member of the interventional radiology community as recognized through his induction as a Fellow of the Society of Interventional Radiology, and has been awarded the CIRA award from the Canadian Association of Interventional Radiology (CAIR) in recognition of his extraordinary contribution to the practice of IR in Canada and worldwide.

Dr. Miles Mannas is a clinical assistant professor of Urology at the Department of Urologic Sciences and Senior Research Scientist at the Vancouver Prostate Centre. He completed Urology training at the University of British Columbia and Urologic Oncology fellowship at NYU Langone Health, a centre leading improvement in the diagnosis and treatment of localized prostate cancer. It was here that he gained expertise in image guided diagnostics and therapeutics for prostate cancer. During fellowship, Dr. Mannas also undertook a Master’s of Science in Clinical Investigation, with a focus on Health Innovation and Technology. The focus of his fellowship and Master’s research was the validation of human and artificial intelligent interpretation of stimulated Raman histology, and application to real-time radical prostatectomy and cryosurgical ablation margin assessments.

Medical Oncologist, BC Cancer, Vancouver Centre
Clinical Assistant Professor, University of British Columbia, Division of Medical Oncology.

Dr. Maurice-Dror is a medical oncologist at BC Cancer-Vancouver Centre. She undertook her Medical Oncology specialist training in Haifa, Israel, where she was actively involved in clinical research as a Principal Investigator in the Genitourinary and early phase clinical trial unit, leading various international clinical trials. In 2022, Corinne completed a 2 year fellowship at BC Cancer focusing on genitourinary malignancies.
Her research interests include clinical and translational aspects of prostate cancer, specifically, prognostic and predictive biomarkers in metastatic prostate cancer.

Victoria, BC
Dr. Metcalfe was born in Edmonton. He attended the UofA for Medical School, UBC for Residency and then went on to do his fellowship at MD Anderson Cancer Center.
Dr. Metcalfe has lived on Vancouver Island for the past 6 years and is married with two children.

Community Urologist
Victoria, BC

Dr. Miller is a Radiation Oncologist and the Regional Medical Director at the BC Cancer - Centre for the North and a proud Wheelin’ Warrior. She trained at the University of British Columbia with residency at the BC Cancer and subsequent international fellowship in Sydney, Australia. Clinically, she is involved in the treatment of several types of cancer with a special interest in Genitourinary and Lymphoid malignancies as well as Rapid Access to Palliative Radiotherapy. As a physician leader in the North, she has focused on Centre for the North’s vision to bring cancer care closer to home including development of Telehealth systems to support this work. Our current research priority is Precision Radiotherapy for Oligo Metastatic Cancers. Dr. Miller is originally from the west coast and moved to Prince George for the opening of the Centre for the North in 2012.

Dylan Narinesingh is originally from Trinidad and Tobago. He did his residency in Cape Town in Clinical Oncology after which he practiced in West Indies and held numerous administrative posts before migrating to beautiful BC with his family. He is a Radiation Oncologist at the Fraser Valley Cancer Center with interest in GU, Breast, Skin and Thyroid.

Dr Pai is a radiation oncologist from BC Cancer – Victoria, subspecializing in genitourinary and skin cancers.
He is a clinical assistant professor in Department of Surgery, Faculty of Medicine at UBC.
He is Affiliate Assistant Professor in Division of Medical Sciences - Island Medical Program, Univ. of Victoria.

BC Cancer Victoria

Dr. Parimi completed his medical school at University of Alberta, and then his internal medicine and medical oncology training at University of Calgary. He then did a prostate cancer fellowship in Vancouver. He currently works as a medical oncologist in Victoria, BC.

He attended UBC Medical School graduating in 2010. He completed Radiation Oncology residency at UBC in 2015. He then completed a brachytherapy fellowship at the Tom Baker Cancer Centre in Calgary. He has been working at BC Cancer Vancouver Centre since 2016 specializing in genitourinary and gastrointestinal treatments. He is a clinical assistant professor in the UBC Department of Surgery. He is currently involved in clinical research including the CIHR-funded OPTiMAL clinical trial for patients with advanced prostate cancer. He is also the present Radiation Oncology Residency Program Director.

Dr. Samarasekera’s medical degree was obtained from the University of British Columbia in 2007. He completed his residency in Urology at UBC, obtaining his fellowship (FRCSC) in 2012. After a two-year fellowship in robotic and laparoscopic surgery at the Cleveland Clinic, Dr. Samarasekera returned to Vancouver. He also holds a degree in mechanical engineering from Queen’s University. Dr. Samarasekera’s urological practice is based out of Surrey, BC.

Dr. Jesse Shustik is a Hematologist-Oncologist in the Department of Medical Oncology, BC Cancer – Surrey, and a Clinical Assistant Professor in the UBC Faculty of Medicine. His clinical practice is focused on the management of hematological and genitourinary malignancies. He has been actively involved in clinical trials and resident supervision and teaching at his centre. He was also his high school debating champion.

Dr. Maryam Soleimani (MD, FRCPC) is a Genitourinary Medical Oncologist at BC Cancer, Vancouver Cancer Centre and a clinical assistant professor at the University of British Columbia. She completed her Bachelor of Science (Hon) and MD degree followed by Internal Medicine residency at the University of Alberta. She then completed Medical Oncology residency at UBC, followed by a clinical and research fellowship, with a special interest in immuno-oncology and renal cell carcinoma. In 2021, she was awarded a prestigious CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Masters Award Canada Graduate Scholarship. Dr. Soleimani is currently completing an MSc in Medicine with Specialization in Translational Medicine. Her research interests include clinical trials, translational research collaboration, and cancer care delivery. Dr. Soleimani is a member of the BC Cancer Complex Immunotherapy Program Committee, and is director of the BC Cancer Von Hippel Lindau (VHL) Clinic.

Dr Telio is a hematologist and medical oncologist practicing at the Burnaby Hospital Cancer Clinic in Burnaby, BC. He completed internal medicine training in Toronto, Ontario and then subsequently hematology and medical oncology training in Vancouver, BC.

Clinical Appointments
2006 – Present
● Consultant Urologist at Burnaby Hospital, Burnaby BC Canada, Royal Columbian Hospital, New Westminster BC Canada and Eagle Ridge Hospital, Port Moody BC Canada
● Clinical Instructor, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia
o Involved with Resident and Medical Student Teaching in the Department of Urologic Sciences

Memberships
Fellow of the Royal College of Surgeons of Canada
College of Physicians and Surgeons of British Columbia
American Urological Association (AUA)
Western Section of AUA
Canadian Urological Association
British Columbia Medical Association
British Columbia Urological Society

Dr. Ryan Urban is originally from Sudbury, Ontario. He trained to be a radiation therapist prior to completing medical school at McMaster University and then radiation oncology residency at the University of British Columbia. After residency he then completed a genitourinary and gynecologic brachytherapy fellowship at Peter MacCallum Cancer Centre in Melbourne, Australia. He currently works at BC Cancer – Vancouver on the genitourinary and gynecologic teams.

Medical Director, Histology and Immunohistochemistry | BC Cancer Vancouver
Director, The David Hardwick Pathology Learning Centre
Associate Member | Vancouver Prostate Centre
Clinical Associate Professor | Dept. Pathology and Laboratory Medicine, UBC
Dr. Wang received his MD degree from Tongji Medical University (Wuhan, China) and his Ph.D. in Pathology from the University of British Columbia (Vancouver, Canada). After completing his Anatomic Pathology residency at the University of British Columbia, he served as a Genitourinary Pathology fellow at the MD Anderson Cancer Center in Houston. After fellowship training, He joined the University of British Columbia and has worked as a consultant pathologist at BC Cancer Vancouver Center since 2017. Dr. Wang is currently the Director of Histology and Immunohistochemistry at BC Cancer and the Director of the David Hardwick Pathology Learning Centre at UBC.

Dr. Wang has a long-term research interest in genitourinary tumors, and authored more than 60 peer-reviewed original articles and chapters of a few books. He was an invited speaker for multiple conferences, diagnostic courses and online lecture series and the reviewer for more than 20 academic journals. He has been awarded the "New Faculty Research Award" from the UBC Faculty of Medicine and the "Excellent in Research and Discovery Award" from the UBC Department of Pathology. As an academic pathologist, Dr. Wang has trained more than 30 residents and fellows and served as a mentor for many of them.

Nathan Wong is a urologist and urologic oncologist at Royal Columbian Hospital. He completed urology residency at McMaster University and urologic oncology fellowship at Memorial Sloan Kettering Cancer Center in New York. He then worked at Westchester Medical Center in New York where he focused on robotic oncology and served as the associate residency program director. He recently moved back to BC and joined the urology group at Fraser Health and looks forward to helping to develop a robotics program.

Dr. Ian Wright is a urologist practicing in the Fraser Health Authority at Ridge Meadows Hospital. He is a clinical instructor at the University of British Columbia in the Faculty of Medicine and continues to teach medical students and UBC urology residents. He received his M.D. form the University of British Columbia, followed by residency training at McMaster University and a fellowship in functional and reconstructive urology at the Vesia, Alberta Bladder Center, University of Calgary. Outside of work you can find Ian coaching his kids soccer and baseball teams, skiing, or on the golf course.

Associate Professor, University of British Columbia
Senior Research Scientist, Vancouver Prostate Centre
Scientist, Michael Smith Genome Sciences Centre, BC Cancer

Dr. Wyatt is an associate professor in Urologic Sciences at the University of British Columbia, Canada. He is a senior research scientist at the Vancouver Prostate Centre and also cross-appointed at BC Cancer. Dr. Wyatt has a DPhil in genetics from the University of Oxford.

His research goals are to identify associations between genomic alterations and patient outcomes in metastatic prostate and bladder cancer, and to translate these findings into clinical biomarkers.

Dr. Wyatt has developed novel laboratory and computational techniques to study plasma circulating tumour DNA (ctDNA). Through application of these methods to clinical trial cohorts, his team has demonstrated that ctDNA is highly representative of metastatic lesions, and that somatic alterations detected in ctDNA can help predict prostate cancer therapy resistance or response.

Dr. Wyatt is the chair of correlative sciences for genitourinary cancer trials run through the Canadian Cancer Trial Group (CCTG). He also serves as a member of the investigational new drug program executive committee. Dr. Wyatt directs the ctDNA screening strategy and the molecular tumor board for the first multi-center phase 2 umbrella trial in metastatic castration-resistant prostate cancer (NCT03385655, NCT02905318).

Head of Surgery, Royal Columbian Hospital
Head of Urology, Fraser Health Authority
Clinical Associate Professor
Department of Urologic Sciences
Faculty of Medicine
University of British Columbia

Dr. Yang is the Head of Surgery at the Royal Columbian Hospital and the Co Regional Head of Urology in the Fraser Health Authority. He specializes in laparoscopic minimally invasive urologic surgery. He is privileged at the Royal Columbian, Eagle Ridge and Burnaby Hospitals. Dr. Yang was born in Vancouver, raised in Delta and currently resides in Burnaby.